| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.266 | 8.649 | 8.461 | 8.342 | 8.200 | 5.657 | 5.975 | 6.405 | 7.158 | 7.451 |
| Total Income - EUR | 14.268 | 8.650 | 8.462 | 8.503 | 8.201 | 5.657 | 5.975 | 12.500 | 7.158 | 7.451 |
| Total Expenses - EUR | 9.476 | 8.361 | 15.034 | 7.997 | 7.058 | 7.768 | 8.331 | 8.237 | 8.351 | 8.446 |
| Gross Profit/Loss - EUR | 4.792 | 289 | -6.573 | 506 | 1.143 | -2.111 | -2.356 | 4.262 | -1.193 | -995 |
| Net Profit/Loss - EUR | 4.364 | 116 | -6.657 | 251 | 897 | -2.268 | -2.536 | 3.895 | -1.257 | -995 |
| Employees | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Sanmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 726 | 1.747 | 2.137 | 1.752 | 1.378 | 1.019 | 671 | 346 | 79 | 0 |
| Current Assets | 9.914 | 9.117 | 4.156 | 4.897 | 6.221 | 5.680 | 5.097 | 4.177 | 3.520 | 2.492 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 463 | 0 | 0 | 0 | 0 |
| Receivables | 1.321 | 1.392 | 837 | 653 | 787 | 373 | 197 | 479 | 545 | 340 |
| Cash | 8.593 | 7.725 | 3.318 | 4.243 | 5.434 | 4.844 | 4.900 | 3.698 | 2.975 | 2.152 |
| Shareholders Funds | 8.074 | 8.119 | 1.324 | 1.551 | 2.417 | 104 | -2.434 | 1.454 | 192 | -804 |
| Social Capital | 45 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 2.566 | 2.746 | 4.969 | 5.098 | 5.182 | 6.958 | 8.208 | 3.134 | 3.440 | 3.484 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanmed S.r.l.